Insulin infusion reduces hepatocyte growth factor in lean humans

Research output: Contribution to journalJournal articleResearchpeer-review

  • Barbora de Courten
  • Maximilian de Courten
  • Sonia Dougherty
  • Josephine M Forbes
  • Jenna R Potts
  • Robert V Considine
OBJECTIVE: Plasma Hepatocyte Growth Factor (HGF) is significantly elevated in obesity and may contribute to vascular disease, metabolic syndrome or cancer in obese individuals. The current studies were done to determine if hyperinsulinemia increases plasma HGF. MATERIALS/METHODS: Twenty-two participants (10 women/12 men, BMI 20.6-34.5 kg/m(2), age 18-49 years) underwent a hyperinsulinemic euglycemic clamp with measurement of HGF at baseline and steady state. Relationships between baseline HGF, anthropometrics, triglycerides, liver enzymes, c-reactive protein and adiponectin were also evaluated. RESULTS: Fasting HGF was positively correlated (P
Original languageEnglish
JournalMetabolism
Volume62
Issue number5
Pages (from-to)647-650
Number of pages4
ISSN0026-0495
DOIs
Publication statusPublished - May 2013

ID: 43232861